Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Encepur follow-up study of antibody persistence in previously vaccinated children and adolescents
2009-010145-31Phase 4Completed
- Sponsor
- Novartis
- Start
- Feb 2009
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Tick-borne encephalitis vaccine in tick-borne encephalitis (TBE), sponsored by Novartis. Primary endpoint: Proportion of subjects with neutralizing antibody titers at least 10. Started Feb 2009; status: completed.
02
Drugs
Tick-borne encephalitis vaccine
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on 2009-010145-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010145-31.